Catalyst Wire Dossier Catalyst Wire Dossier

HS-10561 Capsule

· Jiangsu Hansoh Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10561 Capsule, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria. [Phase 1, Phase 2]

See pricing